![Kenneth A. Buckfire](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kenneth A. Buckfire
Fondateur chez Miller Buckfire & Co. LLC
Provenance du réseau au premier degré de Kenneth A. Buckfire
Entité | Type d'entité | Industrie | |
---|---|---|---|
University of Michigan
408
| College/University | Other Consumer Services | 408 |
The Trustees of Columbia University in The City of New York
343
| College/University | Other Consumer Services | 343 |
New York Philharmonic
![]() New York Philharmonic Movies/EntertainmentConsumer Services New York Philharmonic provides live theatrical presentations. The company was founded in 1842 and is headquartered in New York, NY.
81
| Non-Profit Organization | Movies/Entertainment | 81 |
Weill Cornell Medical College
68
| College/University | Other Consumer Services | 68 |
Miller Buckfire & Co. LLC
![]() Miller Buckfire & Co. LLC Investment ManagersFinance Miller Buckfire & Co. LLC operates as an investment bank, which provides corporate finance and strategic advisory services. It focuses on addressing transformational issues of clients such as recapitalizations, acquisitions, sales and divestitures, and debt and equity financing transactions. The company was founded by Kenneth A. Buckfire and Henry S. Miller in 2002 and is headquartered in New York, NY.
28
| Subsidiary | Investment Managers | 28 |
Amyl Therapeutics SRL
![]() Amyl Therapeutics SRL BiotechnologyHealth Technology Amyl Therapeutics SRL is a Belgian biotech company that uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-? (A?), tau, and ?-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases. Amyl Therapeutics is based in Liege, BE and was founded in November 2020 by Drs. The company's therapies based on the clarity technology platform are designed to prevent the further accumulation of aggregates and clear existing aggregates from the peripheral organs and the brain, while also blocking further cell-to-cell spread of misfolded proteins. Florent Gros and Pierre Vandepapelière. Pierre Vandepapelière has been the CEO since incorporation.
4
| Holding Company | Biotechnology | 4 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Kenneth A. Buckfire via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Lincoln Center for the Performing Arts, Inc.
![]() Lincoln Center for the Performing Arts, Inc. Movies/EntertainmentConsumer Services Lincoln Center for the Performing Arts, Inc. provides entertainment services. It offers dance, music, film, opera, theater, family, and festivals and programs. The company was founded by Dwight D. Eisenhower on May 14, 1959 and is headquartered in New York, NY. | Movies/Entertainment | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | President Undergraduate Degree Masters Business Admin | |
Fordham University
![]() Fordham University Other Consumer ServicesConsumer Services Fordham University provides college and university. It offers undergraduate colleges and graduate & professional schools. The company was founded in 1841 and is headquartered in Bronx, NY. | College/University | Director/Board Member Director/Board Member Director/Board Member | |
Goldman Sachs & Co. LLC
![]() Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Investment Banks/Brokers | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
NewYork-Presbyterian Hospital
![]() NewYork-Presbyterian Hospital Hospital/Nursing ManagementHealth Services NewYork-Presbyterian Hospital offers healthcare services. Its services include surgery, corporate health, nephrology, dermatology, cardiology, hepatology, vascular care, emergency care, and ambulatory care. The company was founded in 1771 and is headquartered in New York, NY. | Hospital/Nursing Management | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
New York University | College/University | Director/Board Member Graduate Degree | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
The Rockefeller University | College/University | Director/Board Member Director/Board Member | |
Metropolitan Opera Association, Inc.
![]() Metropolitan Opera Association, Inc. Movies/EntertainmentConsumer Services Metropolitan Opera Association, Inc. organizes and performs opera shows in its residence at the Lincoln Center of Performing Arts. The firm offers services in association with sponsors, such as Texaco. It produces radio, television and compact disk recordings of the performances and distributes them around the world. The company was founded in 1883 and is headquartered in New York, NY. | Movies/Entertainment | Director/Board Member Director/Board Member | |
McKinsey & Co., Inc.
![]() McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
Cornell University
![]() Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Yale University | College/University | Undergraduate Degree Undergraduate Degree | |
Committee of 100
![]() Committee of 100 Investment Trusts/Mutual FundsMiscellaneous Committee of 100 provides grant making services. The non-profit company is based in New York, NY. The company was founded in 1988 by Henry Alfred Kissinger, Ieoh Ming Pei. | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member | |
Brown University | College/University | Undergraduate Degree Undergraduate Degree | |
Columbia Business School | College/University | Masters Business Admin Masters Business Admin | |
Real Estate Board of New York, Inc.
![]() Real Estate Board of New York, Inc. Miscellaneous Commercial ServicesCommercial Services Real Estate Board of New York, Inc. operates as a real estate trade association. It represents commercial, residential, and institutional property owners, builders, managers, investors, brokers, and salespeople; banks, financial service companies, utilities, attorneys, architects, and contractors. The company was founded in 1896 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
The Metropolitan Museum of Art
![]() The Metropolitan Museum of Art Other Consumer ServicesConsumer Services The Metropolitan Museum of Art operates as an arts institution that maintains a museum and library of art, encouraging and developing the study of the fine arts, and the application of arts to manufacture and practical life. The company was founded in 1870 and is headquartered in New York, NY. | Other Consumer Services | Director/Board Member Corporate Officer/Principal | |
NEOVACS | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Citizens Budget Commission, Inc.
![]() Citizens Budget Commission, Inc. Miscellaneous Commercial ServicesCommercial Services Citizens Budget Commission, Inc. operates an organization that influences constructive changes in the finances and services. It researches and analyzes the city's finances and fiscal affairs of state government and evaluates the management of city government. The company was founded in 1932 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Harvard Law School | College/University | Graduate Degree Graduate Degree | |
Anokion SA
![]() Anokion SA Medical/Nursing ServicesHealth Services Anokion SA provides technology for retraining white blood cells to induce therapeutic immune tolerance. The firm?s approach to antigen-specific immune tolerance can be translated to virtually any protein in numerous clinical indications. The company was founded by Jerffery Hubbell, Melody Swartz, Stephan Kontos, Oscar Buset, Kristen M. Lorentz and David A. Lowin and is headquartered in Ecublens, Switzerland. | Medical/Nursing Services | Director/Board Member | |
Swissvention Partners GmbH | Chief Executive Officer | ||
CAPTOR THERAPEUTICS SPOLKA AKCYJNA | Pharmaceuticals: Major | Director/Board Member | |
Priothera Ltd.
![]() Priothera Ltd. BiotechnologyHealth Technology Priothera Ltd. engages in the development of orally delivered sphingosine-1-phosphate (S1P) receptor modulators for hematological malignancies. The company was founded by Florent Gros, Shaval Patel, and Brice Suire in 2020 and is headquartered in Dublin, Ireland. | Biotechnology | Chief Executive Officer | |
Oculis SA
![]() Oculis SA Miscellaneous Commercial ServicesCommercial Services Oculis SA focuses on ophthalmic drugs and novel drug delivery to the eye. The Oculis drug delivery platform consists of a novel technique to facilitate drug absorption to both anterior and posterior parts of the eye. The advantage is a drug delivery system where diseases of the posterior part of the eye can be treated with a simple topical application. The Oculis drug delivery platform allows diseases such as DME (diabetic macular edema) at the posterior part of the eye to be treated with a non-invasive topical application. The company was founded by Einar Stefansson and Thorsteinn Loftsson in 2003is headquartered in Pully, Switzerland. | Miscellaneous Commercial Services | Chairman | |
binx health, inc.
![]() binx health, inc. Information Technology ServicesTechnology Services Binx Health, Inc. develops and provides in vitro point-of-care (POC) testing on diseases such as sexually transmitted infections, neonatal sepsis and hospital acquired infections. Its technology products include in diagnostic and immunoassay platform, rapid POC, and nucleic acid detection technology. The company was founded by John Clarkson in 2005 and is headquartered in Trowbridge, the United Kingdom. | Information Technology Services | Director/Board Member | |
Vivet Therapeutics SAS
![]() Vivet Therapeutics SAS BiotechnologyHealth Technology Vivet Therapeutics SAS develops novel gene therapy treatments for inherited metabolic diseases. The firm offers its services under the categorizers of Biopharma, Biotechnology and Health Care. The company was founded by Jean-Philippe Combal, Gloria Gonzalez-Aseguinolaza and Jens Kurth on July 26, 2016 and is headquartered in Paris, France. | Biotechnology | Chairman | |
Inflazome Ltd.
![]() Inflazome Ltd. Pharmaceuticals: MajorHealth Technology Inflazome Ltd. engages in developing therapeutic medicines for inflammatory diseases. It manufactures and supplies medicines for muckle wells, type 2 diabetes, atherosclerosis, hypertension, gout, osteoarthritis, rheumatoid arthritis, Parkinson, Alzheimer, and multiple sclerosis. The company was founded by Matthew A. Cooper and Luke O'Neill in 2016 and is headquartered in Dublin, Ireland. | Pharmaceuticals: Major | Director/Board Member | |
Adicet Therapeutics, Inc.
![]() Adicet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adicet Therapeutics, Inc. operates as a biopharmaceutical company focuses on the development of cell immunotherapies. It engages in the design and development of immunotherapies for cancer and other disease indications with a focus on novel universal immune cell therapies. The company was founded by Aya Jakobovits in 2014 and is headquartered in Beverly Hills, CA. | Pharmaceuticals: Major | Director/Board Member | |
Kanyos Bio, Inc.
![]() Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Kanyos Bio, Inc. engages in the provision of immune tolerance technology solutions. It develops antigen-specific for treatment of type-1 diabetes and celiac disease. The company was founded by Jeffrey Hubbell, Stephan Kontos, Oscar Buset, Kristen M. Lorentz, and David A. Lowin in 2015 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
DELTA AIR LINES, INC. | Airlines | Corporate Officer/Principal | |
École Supérieure de Biothechnologie Strasbourg | College/University | Graduate Degree | |
NESTLÉ S.A. | Food: Major Diversified | Corporate Officer/Principal | |
Opsona Therapeutics Ltd.
![]() Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Opsona Therapeutics Ltd. operates as a immunology drug development company. It focuses on novel therapeutics and specializes in the prevention and treatment of solid organ transplantation, cancer, diabetes, autoimmune, inflammatory and Alzheimer’s diseases. The firm developed OPN-305, an antibody to reduce pro-inflammatory cytokine production, which is now at the clinical testing phase. The company was founded by Luke O'Neill, Kingston Mills and Dermot Kelleher in 2004 and is headquartered Dublin, Ireland. | Pharmaceuticals: Major | Director/Board Member | |
GENSIGHT BIOLOGICS S.A. | Pharmaceuticals: Major | Director/Board Member | |
MERUS N.V. | Biotechnology | Director/Board Member | |
Cellerix SA
![]() Cellerix SA Pharmaceuticals: GenericHealth Technology Founded in 2004, Cellerix is a biopharmaceutical company that develops innovative treatments based on cell therapy. Cellerix was founded within the Genetrix Group, group of biotechnology companies specialising in biomedicine. The Genetrix Group began its activities in 2001 at the National Centre for Biotechnology (CNB), which belongs to the Spanish Research Council (CSIC). One of the main objectives of Genetrix is to convert basic research results into therapeutic realities. Cellerix is leading the development of a new generation of medicines using expanded adult stem cells from adipose tissue (eASCs). Development is at a clinically advanced stage and the results from clinical trials in Phase I and II have been very promising. Obtaining these eASCs has big advantages because the process makes use of tissue that is almost always discarded from surgical procedures such as liposuction. eASCs have the capacity to activate physiological repair mechanisms through interaction with affected tissue. This technology represents a revolution in the treatment of some diseases that cannot satisfactorily be cured at present. Cellerix is working actively to adapt this new therapeutic strategy to treat autoimmune diseases such as inflammatory bowel disease. The main goal of the company is to market new tools for treating these diseases, which have a considerable negative impact of the quality of life of the sufferers. Cellerix also researches and develops medicines in other areas such as the development of skin equivalents, which are initially intended for the treatment of hereditary diseases such as epidermolysis bullosa. | Pharmaceuticals: Generic | Director/Board Member | |
MyoPowers Medical Technologies France SAS
![]() MyoPowers Medical Technologies France SAS Medical SpecialtiesHealth Technology MyoPowers Medical Technologies France SA operates as a medical device company. It specializes in muscle technologies to restore or improve muscle function. The firm also develops implantable medical devices for the treatment of severe stress urinary incontinence. The company was founded by Piergiorgio Tozzi and Daniel Hyoz in June 2004 and is headquartered in Lausanne, Switzerland. | Medical Specialties | Director/Board Member | |
Inland Fiber Group LLC
![]() Inland Fiber Group LLC Forest ProductsNon-Energy Minerals Inland Fiber Group LLC is a private company that owns and manages timberland. The company is based in Klamath Falls, OR and has subsidiaries in the United States. | Forest Products | Corporate Officer/Principal | |
Gate Gourmet, Inc.
![]() Gate Gourmet, Inc. Other TransportationTransportation Gate Gourmet, Inc. provides airline-catering services. It focuses on integrated supply chain management, in-flight solutions and retail concepts. The company was founded by David Bonderman in 1992 and is headquartered in Reston, VA. | Other Transportation | Corporate Officer/Principal | |
Endomaster Pte Ltd.
![]() Endomaster Pte Ltd. Medical SpecialtiesHealth Technology Endomaster Pte Ltd. develops EndoMaster EASE System. The EndoMaster EASE System is the robotic-assisted system that can effectively remove gastro-intestinal tumors endoscopically without the need for surgical incisions. The company was founded by Louis Phee and Khek Yu Ho and is headquartered in Singapore. | Medical Specialties | Director/Board Member | |
Imcheck Therapeutics SAS
![]() Imcheck Therapeutics SAS Pharmaceuticals: MajorHealth Technology Imcheck Therapeutics SAS operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research. The company was founded by Olive Daniel in 2015 and is headquartered in Marseille, France. | Pharmaceuticals: Major | Director/Board Member |
Statistiques
Internationale
Etats-Unis | 30 |
France | 8 |
Suisse | 5 |
Irlande | 4 |
Pologne | 2 |
Sectorielle
Health Technology | 18 |
Consumer Services | 16 |
Commercial Services | 5 |
Transportation | 5 |
Health Services | 4 |
Opérationnelle
Director/Board Member | 331 |
Corporate Officer/Principal | 179 |
Chairman | 72 |
Chief Executive Officer | 56 |
Independent Dir/Board Member | 56 |
Relations les plus connectées
Insiders | |
---|---|
Henry Stephen Miller | 67 |
Jackson Tai | 38 |
Derace L. Schaffer | 37 |
Pamela Thomas-Graham | 33 |
Harold Mitchell | 29 |
Florent Gros | 28 |
Usama Fayyad | 26 |
Paul Bernard Guenther | 24 |
Lodewijk J. R. de Vink | 22 |
Benjamin Harris | 20 |
Golnar Khosrowshahi | 20 |
Alexander Klabin | 20 |
Prokopios Tsirigakis | 18 |
Larry Silverstein | 14 |
Mike Sayama | 14 |
- Bourse
- Insiders
- Kenneth A. Buckfire
- Connexions Sociétés